Yakult Honsha Co Ltd
Consumer Staples
Current price
Target price 00%
Ranks rating
76
Position in sub-industry
898 / 1423
Position in country
3489 / 4811
Return on Assets, %
6.8
3.1
Net income margin, %
14.5
3.2
EBITDA margin, %
20.4
8.6
Debt to Equity, %
11.8
41.4
Intangible assets and goodwill, %
0.7
0.9
Revenue CAGR 3Y, %
5.9
9.4
Total Equity change 1Y, %
1.9
0.5
Revenue Y, % chg
1.3
0
P/E
19.2
17.1
P/BV
1.6
1.2
P/S
2
0.7
EV/S
1.7
0.9
EV/EBITDA
9.5
8.9
Average Analyst recommendation
Hold
Hold
Average upside forecasts, %
131.1
20.3
Forward P/E
16.9
15
Dividend Yield, %
3.6
2.3
Forward Dividend Yield, %
4.1
0.2
Expected dividend per share
0.3
0
Payout Ratio, %
32.7
27.4
Competitors
Ranks
-
Yamazaki Baking Co Ltd
00%
-
Toyo Suisan Kaisha Ltd
00%
-
Ajinomoto Co Inc
00%
-
NH Foods Ltd
00%
-
Nissin Foods Holdings Co Ltd
00%
-
Nichirei Corp
00%
-
Kikkoman Corp
00%
-
Nisshin Seifun Group Inc
00%
-
Yakult Honsha Co Ltd
00%
-
Meiji Holdings Co Ltd
00%
Ready-made portfolio of the best Russian stocks
- Created by artificial intelligence
- Verified by analysts
- Available even to beginners
Company information
Country
Japan
Sector
Consumer Staples
Industry group
Food, Beverage & Tobacco
Industry
Food Products
Sub-sector
Consumer Staples
Capitalization (millions of $)
6590.9
Ticker
YKLTY.PK
ISIN
US9845411027
IPO date
1980-01-23
Availability on Russian exchanges
No
Reporting for
2024-02-13
Date fact. publication of reports
2023-12-31
Company Description
YAKULT HONSHA CO.,LTD. is a Japan-based company mainly engaged in the manufacture and sale of dairy products and pharmaceuticals. The Company operates in three business segments. The Beverages and Food Manufacturing and Sale segment is engaged in the manufacture and sale of dairy products, beverages, noodles and healthy food, the purchase and sale of materials, as well as the transportation business. The Company operates business in Japan, the Americas, Europe, Asia and Oceania. The Pharmaceuticals Manufacturing and Sale segment is engaged in the manufacture and sale of anticancer drugs and other ethical drugs. The Others segment is engaged in the production and sale of cosmetics, as well as the operation of professional baseball clubs.
A step towards better analytics
- find the best promotions through the Screener
- keep an eye on stock valuation
- download detailed reports
and much more after free registration
RegistrationMore convenient from your phone? Download: